CD15
更新时间：2017-02-06 17:13:18
概述：
诊断要点：
|
|
|
|
|
||||
|
公司 |
克隆号 |
即用型（ml） |
原液（ml） |
||||
|
基因科技 |
MMA |
/ |
2 |
4 |
7 |
/ |
0.2 |
|
赛诺特 |
Carb-3 |
1 |
3 |
6 |
/ |
0.1 |
0.2 |
|
MMA |
1 |
3 |
6 |
/ |
0.1 |
0.2 |
|
|
中杉金桥 |
MMA+BY87 |
1.5 |
3 |
6 |
/ |
0.1 |
0.2 |
|
安必平 |
MMA |
1.5 |
3 |
6 |
/ |
0.1 |
0.2 |
|
福建迈新 |
Carb-3 |
1 |
3 |
6 |
/ |
/ |
0.2 |
|
百凌生物 |
MMA |
1.5 |
/ |
/ |
7 |
0.1 |
1.0 |
参考文献：
Ramalingam P, Malpica A, Silva EG,et al,The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.Am J Surg Pathol. 2004 Nov;28(11):1499-505.
Zirker TA, Silva EG, Morris M,et al,Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.Am J Clin Pathol. 1989 May;91(5):511-4.
Hodgkin lymphoma: membranous, diffuse cytoplasmic or Golgi staining of Reed-Sternberg cells; CD15 staining is used to confirm diagnosis, or to differentiate Hodgkin lymphoma (CD15+) from anaplastic large cell lymphoma (usually CD15-)
